Regression of experimental liver tumor after distant intra-hepatic injection of cytosine deaminase-expressing tumor cells and 5-fluorocytosine treatment

Int J Mol Med. 2000 Mar;5(3):275-8. doi: 10.3892/ijmm.5.3.275.

Abstract

Cytosine deaminase (CD) gene of E. coli converts the non-toxic compound 5-fluorocytosine (5-FC) into 5-fluorouracil. We have introduced a vector expressing the CD gene in a rat colon carcinoma cell line. Expression of the CD gene confers 5-FC sensitivity to these cells in vitro and in vivo. In a bifocal model consisting in a simultaneous engrafment of a CD+ tumor on one lobe of the liver and a wild-type parental tumor on the opposite lobe, treatment with 5-FC results in regression of both type of tumors, indicating the existence of a distant bystander effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colonic Neoplasms / pathology
  • Cytosine Deaminase
  • Flucytosine / pharmacology*
  • Genetic Therapy
  • Injections
  • Liver Neoplasms, Experimental / pathology
  • Liver Neoplasms, Experimental / therapy*
  • Male
  • Neoplasm Transplantation
  • Nucleoside Deaminases / genetics*
  • Nucleoside Deaminases / metabolism*
  • Rats
  • Tumor Cells, Cultured

Substances

  • Flucytosine
  • Nucleoside Deaminases
  • Cytosine Deaminase